Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
PDF
In the News
Early Case Management Speeds RTW, Report Says
Workers' Comp
News Release
Risk & Insurance: Early Case Management Speeds RTW
Workers' Comp
News Release
Genex Services White Paper Examines the Tipping Points of Routine Workers' Compensation Claims
Highlights value of early case management intervention for optimal RTWFebruary 18, 2015 – Wayne, Pa.
Workers' Comp
White Paper
Tipping Points: When Good Claims Go Bad
These claims create quandaries for carriers and payors. Unanticipated cost escalation is a problem that cannot be ignored.
WorkCompWire
Article
Social Success: Twitter Chat Allows Workers’ Comp Pros to Share Ideas
Workers' Comp
News Release
Workers' Comp Leaders to Host First-Ever Industry Twitter Chat
Jan.